Monitoring and Long-Term Outlook for Your Child
At a Glance
Children with carbonic anhydrase VA deficiency have varied long-term outcomes: many have typical development with prompt care, while others need support for developmental delays, seizures, or poor growth. Regular follow-up is essential because illness can trigger severe relapses.
The long-term outlook for a child with Carbonic Anhydrase VA (CA-VA) deficiency is a journey that changes over time. Because this condition was only recently discovered, researchers are still learning about how children grow and develop into adulthood [1]. What we do know is that proactive monitoring and rapid treatment of illnesses are the most effective ways to protect your child’s long-term health [2][3].
Understanding the Risk of Relapse
While many children have their most severe crisis in the newborn period, the risk of a metabolic relapse does not completely disappear as they get older [1][4].
- Triggers: Most relapses are triggered by common childhood stressors, such as fever, vomiting, or infections [2].
- Frequency: Many children only experience one major crisis in their lifetime, but some may have recurrent episodes of high ammonia (hyperammonemia) [5][1]. In one study of a specific genetic founder variant cohort, nearly 40% (7 of 18) of children had more than one crisis, with some episodes occurring as late as age 8 [1][2].
- Severity: Unlike some conditions that get milder over time, the severity of a CA-VA crisis can remain high if it is not caught early. This is why having a “sick-day” plan is a lifelong necessity [4].
Long-Term Development and Growth
The “prognosis”—or expected outcome—for children with CA-VA deficiency is highly variable. Outcomes can range from typical cognitive development to more significant challenges [1][5].
- Favorable Outcomes: Many children who receive a prompt diagnosis and treatment go on to have typical cognitive development, growth, and motor skills [5][2].
- Potential Challenges: Some children may experience developmental delays (such as being slow to walk or talk), microcephaly (a smaller-than-expected head size), or intellectual disabilities [1][6].
- Poor Weight Gain: Because the body’s metabolism is under stress, some children may struggle to gain weight or grow at a typical rate, which requires close coordination with a metabolic dietitian [1][2].
The Role of Brain Imaging
A brain MRI is a powerful tool for your medical team. It provides a “snapshot” of how a metabolic crisis may have affected the brain, and scans are obtained according to clinical circumstances [5].
- Establishing a Baseline: Some children will have an MRI shortly after their first crisis. The pattern of changes on this scan can help doctors understand the extent of the injury [5].
- Predicting Outcomes: Cortical, basal-ganglia, or brainstem findings provide probabilistic information rather than an individual prediction of outcome [5].
- Tracking Healing: In some cases, follow-up MRIs show that some changes improve while others persist once the ammonia and acid levels are stabilized. Developmental follow-up is essential regardless of the scan [5].
Routine Monitoring Schedule
To stay ahead of potential issues, your child will need regular check-ups even when they are feeling well. Laboratory, growth, developmental, neurological, and imaging follow-up must be set by the treating metabolic team [3]. A customized schedule may include:
- Metabolic Labs: Regular blood tests to monitor ammonia, acid-base status, and nutritional markers. Ammonia testing while well may not be needed for every child and can be affected by collection and transport problems [3].
- Growth Tracking: Frequent measurements of height, weight, and head circumference to ensure your child is getting enough nutrition to grow without stressing their metabolism [1][2].
- Developmental Screenings: Regular evaluations of speech, motor skills, and learning progress to catch any delays early and start supportive therapies like physical or occupational therapy [1][6].
- Neurological Follow-up: Monitoring for potential seizures or changes in muscle tone, which can sometimes appear months or years after a crisis [7][1].
While the “ultra-rare” nature of CA-VA deficiency means there are still many unknowns, the evidence shows that when families and doctors work together to prevent catabolism and manage illnesses, children have the best chance at a healthy, active future [2][3].
Common questions in this guide
What long-term development can we expect with CA-VA deficiency?
Can CA-VA deficiency cause another metabolic crisis after infancy?
What monitoring does my child need when they are well?
Can a brain MRI predict my child's future development?
What changes should I report after my child's metabolic crisis?
How can school or daycare help keep my child safe?
Get notified when new evidence is published on Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (7)
- 1
A founder mutation in CA5A causing intrafamilial and interfamilial phenotypic variability in a cohort of 18 patients with carbonic anhydrase VA deficiency.
Al-Thihli K, Al Hashmi N, Al Balushi A, et al.
JIMD reports 2024; (65(4)):226-232 doi:10.1002/jmd2.12426.
PMID: 38974611 - 2
Long-Term Follow-Up of Patients With Mitochondrial Carbonic Anhydrase VA Deficiency. A Case Report and Literature Review.
Shurrab S, Mobarak A, Horvath G, et al.
JIMD reports 2026; (67(4)):e70102 doi:10.1002/jmd2.70102.
PMID: 42371568 - 3
Antenatal and Neonatal Management of Siblings With Carbonic Anhydrase VA Deficiency.
Manoy S, Minto T, Demetriou K, et al.
JIMD reports 2026; (67(2)):e70076 doi:10.1002/jmd2.70076.
PMID: 41737902 - 4
Recurrent hyperammonaemia in a patient with carbonic anhydrase VA deficiency.
Stockdale C, Bowron A, Appleton M, et al.
JIMD reports 2022; (63(6)):536-539 doi:10.1002/jmd2.12322.
PMID: 36341166 - 5
Neuroimaging Findings in Carbonic Anhydrase VA Deficiency: A Case Series Highlighting Diagnostic and Prognostic Patterns in a Potentially Reversible Mitochondrial Dysfunction.
Fragoso DC, Al-Ajmi E, Cardenas AM, et al.
AJNR. American journal of neuroradiology 2026; (47(1)):200-207 doi:10.3174/ajnr.A8948.
PMID: 41022560 - 6
A novel homozygous CA5A gene deletion in carbonic anhydrase VA deficiency presenting as developmental delay without metabolic crisis.
Bin Hadyan MF, Saleh MA, Aldalaqan S, et al.
Molecular genetics and metabolism reports 2026; (46()):101294 doi:10.1016/j.ymgmr.2026.101294.
PMID: 41736722 - 7
A case of carbonic anhydrase type VA deficiency presenting as West syndrome in an infant with a novel mutation in the CA-VA gene.
Mani Urmila N, Kewalramani D, Balakrishnan U, Manokaran RK
Epilepsy & behavior reports 2022; (20()):100573 doi:10.1016/j.ebr.2022.100573.
PMID: 36411877
This page is for informational purposes only and does not constitute medical advice. Your child's metabolic team should set the monitoring schedule and provide individualized sick-day and treatment instructions.